688670 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Jiangsu gdk Biotechnology Co., Ltd. engages in the research and development, production and sale of human vaccines. Its products include freeze-dried human rabies, quadrivalent influenza virus, 23-valent pneumococcal polysaccharide, freeze-dried live attenuated varicella, freeze-dried live attenuated herpes zoster, 13-valent pneumococcal polysaccharide conjugate and recombinant shingles vaccines. The company was founded by Yun De Hou and Jing Zhao on December 29, 2008 and is headquartered in Taizhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688670 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company